National Research Corporation (NRC)
USD 11.72
(-5.52%)
USD 11.72
(-5.52%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 29.47 Million USD | 66.59% |
| 2022 | 17.69 Million USD | -20.56% |
| 2021 | 22.26 Million USD | -16.11% |
| 2020 | 26.54 Million USD | -10.9% |
| 2019 | 29.79 Million USD | -12.82% |
| 2018 | 34.17 Million USD | 0.0% |
| 2017 | - USD | -100.0% |
| 2016 | 857 Thousand USD | -74.32% |
| 2015 | 3.33 Million USD | -41.86% |
| 2014 | 5.74 Million USD | -29.79% |
| 2013 | 8.17 Million USD | 3533.78% |
| 2012 | 225 Thousand USD | -98.26% |
| 2011 | 12.95 Million USD | -9.65% |
| 2010 | 14.33 Million USD | 107.63% |
| 2009 | 6.9 Million USD | -17.56% |
| 2008 | 8.37 Million USD | 340.55% |
| 2007 | 1.9 Million USD | -76.19% |
| 2006 | 7.98 Million USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 4.74 Million USD | -3.18% |
| 2003 | 4.9 Million USD | -2.84% |
| 2002 | 5.04 Million USD | -2.43% |
| 2001 | 5.16 Million USD | -2.38% |
| 2000 | 5.29 Million USD | 0.0% |
| 1999 | - USD | -100.0% |
| 1998 | 100 Thousand USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 27.56 Million USD | -6.45% |
| 2024 Q2 | 25.65 Million USD | -6.94% |
| 2024 Q3 | 44.91 Million USD | 75.05% |
| 2023 Q4 | 29.47 Million USD | 108.06% |
| 2023 FY | 29.47 Million USD | 66.59% |
| 2023 Q3 | 14.16 Million USD | -7.77% |
| 2023 Q2 | 15.35 Million USD | -7.09% |
| 2023 Q1 | 16.53 Million USD | -6.56% |
| 2022 Q1 | 21.16 Million USD | -4.98% |
| 2022 Q2 | 20.04 Million USD | -5.28% |
| 2022 Q3 | 18.83 Million USD | -6.02% |
| 2022 Q4 | 17.69 Million USD | -6.09% |
| 2022 FY | 17.69 Million USD | -20.56% |
| 2021 Q4 | 22.26 Million USD | -4.67% |
| 2021 Q1 | 25.49 Million USD | -3.97% |
| 2021 Q2 | 24.43 Million USD | -4.16% |
| 2021 FY | 22.26 Million USD | -16.11% |
| 2021 Q3 | 23.36 Million USD | -4.4% |
| 2020 Q1 | 28.59 Million USD | -4.03% |
| 2020 Q2 | 28.62 Million USD | 0.12% |
| 2020 Q3 | 27.58 Million USD | -3.65% |
| 2020 Q4 | 26.54 Million USD | -3.76% |
| 2020 FY | 26.54 Million USD | -10.9% |
| 2019 Q4 | 29.79 Million USD | -3.82% |
| 2019 Q3 | 30.97 Million USD | -3.62% |
| 2019 Q2 | 32.13 Million USD | -3.26% |
| 2019 Q1 | 33.22 Million USD | -2.79% |
| 2019 FY | 29.79 Million USD | -12.82% |
| 2018 Q3 | 35.1 Million USD | -2.55% |
| 2018 Q4 | 34.17 Million USD | -2.66% |
| 2018 Q2 | 36.02 Million USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | 34.17 Million USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | -100.0% |
| 2017 Q1 | 225 Thousand USD | -73.75% |
| 2017 Q2 | - USD | -100.0% |
| 2017 Q3 | - USD | 0.0% |
| 2016 FY | 857 Thousand USD | -74.32% |
| 2016 Q1 | 2.72 Million USD | -18.37% |
| 2016 Q2 | 2.1 Million USD | -22.65% |
| 2016 Q3 | 1.48 Million USD | -29.52% |
| 2016 Q4 | 857 Thousand USD | -42.29% |
| 2015 FY | 3.33 Million USD | -41.86% |
| 2015 Q2 | 4.54 Million USD | -11.62% |
| 2015 Q4 | 3.33 Million USD | -15.41% |
| 2015 Q3 | 3.94 Million USD | -13.26% |
| 2015 Q1 | 5.14 Million USD | -10.35% |
| 2014 Q4 | 5.74 Million USD | -9.29% |
| 2014 Q2 | 6.91 Million USD | -8.67% |
| 2014 Q1 | 7.56 Million USD | -7.44% |
| 2014 FY | 5.74 Million USD | -29.79% |
| 2014 Q3 | 6.32 Million USD | -8.45% |
| 2013 Q2 | 9.2 Million USD | 4547.98% |
| 2013 Q4 | 8.17 Million USD | -5.35% |
| 2013 Q1 | 198 Thousand USD | -12.0% |
| 2013 FY | 8.17 Million USD | 3533.78% |
| 2013 Q3 | 8.63 Million USD | -6.14% |
| 2012 Q3 | - USD | -100.0% |
| 2012 Q2 | 11.45 Million USD | -4.11% |
| 2012 Q1 | 11.94 Million USD | -7.74% |
| 2012 Q4 | 225 Thousand USD | 0.0% |
| 2012 FY | 225 Thousand USD | -98.26% |
| 2011 Q4 | 12.95 Million USD | 0.26% |
| 2011 Q2 | 13.39 Million USD | -3.4% |
| 2011 Q1 | 13.86 Million USD | -3.27% |
| 2011 FY | 12.95 Million USD | -9.65% |
| 2011 Q3 | 12.91 Million USD | -3.55% |
| 2010 Q1 | 6.35 Million USD | -7.91% |
| 2010 FY | 14.33 Million USD | 107.63% |
| 2010 Q3 | 14.79 Million USD | 140.61% |
| 2010 Q4 | 14.33 Million USD | -3.12% |
| 2010 Q2 | 6.14 Million USD | -3.27% |
| 2009 Q1 | 8.18 Million USD | -2.22% |
| 2009 Q2 | 7.98 Million USD | -2.43% |
| 2009 Q3 | 7.79 Million USD | -2.43% |
| 2009 Q4 | 6.9 Million USD | -11.43% |
| 2009 FY | 6.9 Million USD | -17.56% |
| 2008 Q4 | 8.37 Million USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | -100.0% |
| 2008 Q1 | 351.24 Thousand USD | -81.52% |
| 2008 FY | 8.37 Million USD | 340.55% |
| 2007 FY | 1.9 Million USD | -76.19% |
| 2007 Q1 | 7.6 Million USD | -4.68% |
| 2007 Q2 | 6.07 Million USD | -20.13% |
| 2007 Q3 | 3.77 Million USD | -37.81% |
| 2007 Q4 | 1.9 Million USD | -49.71% |
| 2006 Q4 | 7.98 Million USD | -99.9% |
| 2006 FY | 7.98 Million USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q3 | 8.15 Billion USD | 97400.8% |
| 2006 Q2 | 8.36 Million USD | 0.0% |
| 2005 Q4 | - USD | -100.0% |
| 2005 Q2 | 4.66 Million USD | -0.9% |
| 2005 Q1 | 4.7 Million USD | -0.9% |
| 2005 FY | - USD | -100.0% |
| 2005 Q3 | 4.61 Million USD | -0.9% |
| 2004 FY | 4.74 Million USD | -3.18% |
| 2004 Q4 | 4.74 Million USD | -0.82% |
| 2004 Q3 | 4.78 Million USD | -0.8% |
| 2004 Q2 | 4.82 Million USD | -0.8% |
| 2004 Q1 | 4.86 Million USD | -0.8% |
| 2003 Q1 | 5 Million USD | -0.7% |
| 2003 Q2 | 4.97 Million USD | -0.72% |
| 2003 Q3 | 4.93 Million USD | -0.71% |
| 2003 Q4 | 4.9 Million USD | -0.74% |
| 2003 FY | 4.9 Million USD | -2.84% |
| 2002 Q2 | 5.11 Million USD | -0.56% |
| 2002 Q3 | 5.07 Million USD | -0.79% |
| 2002 FY | 5.04 Million USD | -2.43% |
| 2002 Q4 | 5.04 Million USD | -0.68% |
| 2002 Q1 | 5.14 Million USD | -0.42% |
| 2001 Q2 | 5.23 Million USD | -0.54% |
| 2001 Q4 | 5.16 Million USD | -0.72% |
| 2001 Q3 | 5.2 Million USD | -0.52% |
| 2001 Q1 | 5.26 Million USD | -0.62% |
| 2001 FY | 5.16 Million USD | -2.38% |
| 2000 FY | 5.29 Million USD | 0.0% |
| 2000 Q1 | 12.17 Thousand USD | 0.0% |
| 2000 Q3 | 5.33 Million USD | 41902.93% |
| 2000 Q4 | 5.29 Million USD | -0.67% |
| 2000 Q2 | 12.69 Thousand USD | 4.25% |
| 1999 Q1 | 100 Thousand USD | 0.0% |
| 1999 FY | - USD | -100.0% |
| 1999 Q2 | 100 Thousand USD | 0.0% |
| 1999 Q4 | - USD | -100.0% |
| 1999 Q3 | 100 Thousand USD | 0.0% |
| 1998 Q2 | 100 Thousand USD | 0.0% |
| 1998 FY | 100 Thousand USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q4 | 100 Thousand USD | 0.0% |
| 1998 Q3 | 100 Thousand USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| CareCloud, Inc. | 10.03 Million USD | -193.614% |
| Augmedix, Inc. | 15.3 Million USD | -92.577% |
| BrightSpring Health Services, Inc. Common Stock | 3.33 Billion USD | 99.116% |
| CareCloud, Inc. | 10.03 Million USD | -193.614% |
| HealthEquity, Inc. | 874.97 Million USD | 96.632% |
| iCoreConnect Inc. | 1.42 Million USD | -1975.152% |
| Inovalon Holdings, Inc. | 877.57 Million USD | 96.642% |
| Nutex Health, Inc. | 26.31 Million USD | -11.99% |
| Omnicell, Inc. | 569.66 Million USD | 94.827% |
| OneMedNet Corporation | 465.02 Thousand USD | -6237.321% |
| Progyny, Inc. | 17.24 Million USD | -70.93% |
| Renalytix Plc | 4.33 Million USD | -580.443% |
| Schrödinger, Inc. | 111.01 Million USD | 73.454% |
| Simulations Plus, Inc. | 531 Thousand USD | -5449.906% |
| SOPHiA GENETICS SA | 15.67 Million USD | -88.03% |
| Streamline Health Solutions, Inc. | 9.06 Million USD | -225.061% |
| Ontrak, Inc. | 1.46 Million USD | -1908.862% |
| GE HealthCare Technologies Inc. | 8.74 Billion USD | 99.663% |
| Sharecare, Inc. | 519 Thousand USD | -5578.227% |
| Aclarion, Inc. | - USD | -Infinity% |
| CareMax, Inc. | 21.44 Million USD | -37.434% |
| Bullfrog AI Holdings, Inc. Common Stock | - USD | -Infinity% |
| Forian Inc. | 22.99 Million USD | -28.18% |
| Bullfrog AI Holdings, Inc. Warrants | - USD | -Infinity% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 52.68 Million USD | 44.067% |
| SCWorx Corp. | 90.35 Thousand USD | -32514.349% |
| Minerva Surgical, Inc. | 37.44 Million USD | 21.289% |
| Definitive Healthcare Corp. | 242.56 Million USD | 87.851% |
| 10x Genomics, Inc. | 83.84 Million USD | 64.853% |
| Zhongchao Inc. | 571.86 Thousand USD | -5053.341% |
| Accolade, Inc. | 208.48 Million USD | 85.864% |
| MSP Recovery, Inc. | 678.98 Million USD | 95.66% |
| R1 RCM Inc. | 1.64 Billion USD | 98.212% |
| Spok Holdings, Inc. | 6.9 Million USD | -326.978% |
| Privia Health Group, Inc. | 5.24 Million USD | -461.761% |
| EUDA Health Holdings Limited | 75.11 Thousand USD | -39135.265% |
| TruBridge, Inc. | 198.34 Million USD | 85.142% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 3.33 Billion USD | 99.116% |
| Sharecare, Inc. | 519 Thousand USD | -5578.227% |
| Health Catalyst, Inc. | 228.03 Million USD | 87.076% |
| GoodRx Holdings, Inc. | 647.7 Million USD | 95.45% |
| Premier, Inc. | 11.17 Million USD | -163.832% |
| HealthStream, Inc. | 20.24 Million USD | -45.552% |
| Certara, Inc. | 288.21 Million USD | 89.775% |
| GeneDx Holdings Corp. | 52.68 Million USD | 44.067% |
| Ontrak, Inc. | 1.46 Million USD | -1908.862% |
| SHL Telemedicine Ltd. | 10.43 Million USD | -182.44% |
| CareCloud, Inc. | 10.03 Million USD | -193.614% |
| EUDA Health Holdings Limited | 75.11 Thousand USD | -39135.265% |
| HeartBeam, Inc. | - USD | -Infinity% |
| Mangoceuticals, Inc. | 64.96 Thousand USD | -45265.681% |
| CareMax, Inc. | 21.44 Million USD | -37.434% |
| Healthcare Triangle, Inc. | 888 Thousand USD | -3218.694% |
| Aclarion, Inc. | - USD | -Infinity% |
| OptimizeRx Corporation | 34.23 Million USD | 13.908% |